Page last updated: 2024-11-07

norethindrone acetate and Recrudescence

norethindrone acetate has been researched along with Recrudescence in 4 studies

norethisterone acetate : A 3-oxo Delta(4)-steroid that is norethisterone in which the hydroxy group has been converted to its acetate ester.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Roman, H1
Tran, A1
Villeneuve, JP1
Bilodeau, M1
Willems, B1
Marleau, D1
Fenyves, D1
Parent, R1
Pomier-Layrargues, G1
Høibraaten, E2
Qvigstad, E1
Andersen, TO1
Mowinckel, MC2
Sandset, PM2
de Ronde, H1
Bertina, RM1

Trials

2 trials available for norethindrone acetate and Recrudescence

ArticleYear
The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism--results from a randomized, double-blind, clinical trial.
    Thrombosis and haemostasis, 2001, Volume: 85, Issue:5

    Topics: Biomarkers; Double-Blind Method; Drug Therapy, Combination; Estradiol; Female; Hemostasis; Hormone R

2001
Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial.
    British journal of haematology, 2001, Volume: 115, Issue:2

    Topics: Activated Protein C Resistance; Aged; Double-Blind Method; Drug Combinations; Estradiol; Estrogen Re

2001

Other Studies

2 other studies available for norethindrone acetate and Recrudescence

ArticleYear
Oral contraceptives and endometriosis.
    Human reproduction (Oxford, England), 2011, Volume: 26, Issue:6

    Topics: Contraceptives, Oral; Endometriosis; Female; Humans; Norethindrone; Norethindrone Acetate; Recurrenc

2011
Treatment of chronic bleeding from gastric antral vascular ectasia (GAVE) with estrogen-progesterone in cirrhotic patients: an open pilot study.
    The American journal of gastroenterology, 1999, Volume: 94, Issue:10

    Topics: Aged; Aged, 80 and over; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Estradiol Cong

1999